Post by
MrMugsy on Jan 20, 2022 8:41pm
CRRX - Stephen T - Strong Buy
The #1 institutional pharmacy player with 23% market share.
Stock did well last year, cheap now.
Organic and acquisition growth.
Becoming really well managed.
Automating fulfillment centres to improve margins.
Equity raises caused it to tread water.
Solid baseline, should trend up nicely.
Demographic tailwind.
Getting into medical supply distribution.